|
Status |
Public on Mar 01, 2022 |
Title |
LN3-3M |
Sample type |
RNA |
|
|
Source name |
Treated lymph node
|
Organism |
Mus musculus |
Characteristics |
tissue: lymph node
|
Treatment protocol |
Tumors were injected intratumorally once with 3M-052 or vehicle control, then 4 days later draining lymph nodes were excised.
|
Growth protocol |
B16 tumors were established by subcutaneous inoculation, and allowed to grow until 30-40 mm2 in size
|
Extracted molecule |
total RNA |
Extraction protocol |
Total RNA of dissected tumors was extracted using the RNAqueous kit (Ambion). The RNA quality was checked by using a Bioanalyzer 2100 instrument (Agilent).
|
Label |
biotin
|
Label protocol |
100 nanograms of total RNA was amplified and biotin-labeled through a two-round Eberwine procedure using MessageAmp II and Illumina TotalPrep RNA amplification kits (Ambion).
|
|
|
Hybridization protocol |
Amplified cRNA was hybridized to Illumina mouse WG-6 version 2.0 mouse whole-genome arrays.
|
Scan protocol |
As per Illumina instructions, with detection by Streptavidin-Cy3 conjugate.
|
Description |
replicate 3
|
Data processing |
The non-normalized data were generated by GenomeStudio with background correction. The normalized data were generated from bead-level data by methods previously described (PMID: 20805315). In brief, bead-level values were quantile-normalized, adjusted by a model-based background correction method (PMID: 18450815), trimmed by the 3-MAD method employed by Illumina, and then averaged to give a single probe-level value. After this, the only probe results that are kept for the normalized matrix are those in which the detection p value is <0.05, in at least 25% of the samples. Cy3 fluorescence intensity
|
|
|
Submission date |
Dec 06, 2021 |
Last update date |
Mar 01, 2022 |
Contact name |
Richard Eric Davis |
E-mail(s) |
redavis1@mdanderson.org
|
Phone |
4437456831
|
Organization name |
MD Anderson Cancer Center
|
Street address |
7455 Fannin Street
|
City |
Houston |
State/province |
TX |
ZIP/Postal code |
77054 |
Country |
USA |
|
|
Platform ID |
GPL6887 |
Series (1) |
GSE190261 |
Effect of TLR7/8 dual agonist 3M-052 on B cell response to melanoma |
|